52 results on '"Currier, Judith S"'
Search Results
2. Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-saharan Africa, HPTN 046- a post-hoc analysis
3. Poorer Muscle Quality and Quantity With ART Initiation Is Associated With Greater Inflammation and Immune Activation
4. Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis
5. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding
6. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV
7. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV
8. Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV
9. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa
10. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
11. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men
12. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women
13. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
14. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
15. Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate: AIDS Clinical Trials Group Study A5314
16. Birth Outcomes for Pregnant Women With HIV Using Tenofovir-Emtricitabine
17. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
18. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection
19. The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
20. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery
21. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness
22. Comparison of HBV-active HAART regimens in an HIV–HBV multinational cohort: outcomes through 144 weeks
23. Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial
24. HIV and Atherosclerosis: Moving From Associations to Mechanisms and Interventions
25. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
26. Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort
27. Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County
28. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women
29. A Randomized Trial of Raltegravir Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Women with Lipohypertrophy
30. Sex Differences in Lopinavir and Ritonavir Pharmacokinetics Among HIV-Infected Women and Men
31. Effects of Darunavir/Ritonavir-Based Therapy on Metabolic and Anthropometric Parameters in Women and Men Over 48 Weeks
32. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229
33. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness
34. Postexposure Prophylaxis for HIV Infection
35. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study
36. Determinants of Participation in HIV Clinical Trials: The Importance of Patientsʼ Trust in Their Provider
37. Evaluation of Sex Differences of Fosamprenavir (With and Without Ritonavir) in HIV-Infected Men and Women
38. Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults
39. Getting Smarter - The Toxicity of Undertreated HIV Infection
40. Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil
41. Response to: ‘Carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients’
42. Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure
43. Effect of Nandrolone Decanoate Therapy on Weight and Lean Body Mass in HIV-Infected Women With Weight Loss: A Randomized, Double-blind, Placebo-Controlled, Multicenter Trial
44. Sex differences in HIV: Natural history, pharmacokinetics, and drug toxicity
45. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l
46. Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral Therapy–Induced Increases in CD4+ Cell Count: A Randomized, Double-Blind, Placebo-Controlled Trial
47. Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels
48. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
49. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections
50. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.